A fresh viewpoint on drug discovery, pharma, and biotech

Subscribe | Become an author | Author LogIn


Contact us at to request profile updates/corrections. You must be an official company representative to do so (only requests from corporate emails are accepted).



We bring unparalleled chemical diversity to areas of highest unmet medical need with the team and tools to turn the resulting discoveries into viable, high-impact therapeutics.

Over the last three years, our platform has been validated by pharma partners, helping them increase the chemical diversity of their therapeutic leads, including in cancer and antibiotics. We are now focusing on the discovery and development of novel and differentiated payloads for oncology antibody drug conjugates (ADCs) and have payload programs in various stages of optimization and preclinical development.

Year Founded
United States of America based
$1.3 M
Therapeutic focus
  • Oncology
  • Infectious Diseases
Data type
  • chemical notations
  • SAR
Drug Discovery Strategy
  • Target-based drug discovery (TDD)
  • Modification of natural products
Product type
  • small molecules

Industry Partnerships

2018Bristol-Myers SquibbApply ATLANTIS proprietary drug discovery platform against a series of undisclosed but challenging therapeutic targets.

Posts Mentioning This Company

2018 Brings A Surge Of Activity In The “AI For Drug Discovery” Space - March 15, 2018
Biopharma Insights